MedTrace Logo

Food Effect and Relative Bioavailability Study of VC004 Capsules in Healthy Adult Subjects

NCT06529445 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 84

Last updated 2024-08-29

No results posted yet for this study

Summary

This study will adopt a randomized, open-label, two-period, 2-way crossover design to evaluate Food effect and Relative bioavailability of VC004 Capsules in healthy subjects

Conditions

  • Locally Advanced or Metastatic Solid Tumor Harboring an NTRK Gene Fusion

Interventions

DRUG

High Dose VC004 Capsules

VC004 Capsules qd per period, for two periods

DRUG

Median Dose VC004 Capsules

VC004 Capsules qd per period, for two periods

DRUG

Low Dose VC004 Capsules

VC004 Capsules qd per period, for two periods

Sponsors & Collaborators

  • Jiangsu vcare pharmaceutical technology co., LTD

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-07-22
Primary Completion
2024-08-26
Completion
2024-08-26

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06529445 on ClinicalTrials.gov